Interim results of a Phase I/II prospective dose escalation trial evaluating safety and efficacy of combination 177Lu-PSMA-617 and NOX66 in men with mCRPC post-androgen signaling inhibition and 2 lines of taxane chemotherapy (LuPIN trial)
efficacy of combination 177Lu-PSMA-61... - Advanced Prostate...
efficacy of combination 177Lu-PSMA-617 and NOX66
Written by
George71
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
177Lu-PSMA-617
Previously I did not qualify for the previous 177Lu-PSMA-617 trial because i am not castrate...
After Xtandi, 177Lu-PSMA-617 or BAT?
next?
1. 177Lu-PSMA-617 - https://www.ncbi.nlm.nih.gov/pubmed/27088387
2. Bipolar Androgen Therapy -
Side effects from 177LU PSMA 617
destroy salivary glands because they also exhibit PSMA. Can anyone comment on the side effects of...
Choose Capivasertib or 177Lu-PSMA-617 clinical trial or stick with ADT + radiation?
likely) be randomized (50%) into getting either 177Lu-PSMA-617 + ADT or into standard care control...
177Lu-PSMA-617: Trial shows it's more effective than changing ARPIs
enzalutamide or vice versa, or 177Lu-PSMA-617, a prostate-specific antigen (PSMA)-targeted...
EXPANDED ACCESS FOR Lu-PSMA-617
Overview of 177Lu PSMA trials
Radium-223 and [177Lu]Lu-PSMA
Excellent response to Ac-225-PSMA-617 in South Africa (update)
